Home
Billing codes
J3398

PAYER POLICY CHANGES

J3398 Insurance Policy Changes

HCPCS J3398 is officially defined as "Injection, voretigene neparvovec-rzyl, 1 billion vector genomes." HCPCS J3398 is referenced in 10 tracked payer policy changes from BCBS Tennessee, UnitedHealthcare, and 3 other payers. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS J3398 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

BCBS Tennessee · Effective Oct 31, 2026Medium impact
Velaglucerase Alfa (VPRIV®)
BlueCross BlueShield of Tennessee is implementing a new prior authorization requirement and coverage policy for Velaglucerase Alfa (VPRIV®), an enzyme replacement therapy for Gaucher disease types 1, 2, and 3. The policy requires step therapy, specialized prescriber credentials, baseline diagnostic testing, and clinical evidence of disease before initial approval; continuation therapy requires documented clinical benefit. This policy becomes effective October 31, 2026, and applies to all Tennessee members.
UnitedHealthcare · Effective Feb 11, 2026Medium impact
North Carolina Medicaid: Billing guidance for cell and gene therapy treatments
North Carolina Medicaid now participates in the Cell and Gene Therapy Access Model, requiring prior authorization for specific CGT treatments through UnitedHealthcare Community Plan. Providers must obtain prior auth before billing for listed CGT drugs or face claim denials.
UnitedHealthcare · Effective Feb 11, 2026Medium impact
North Carolina Medicaid: Billing guidance for cell and gene therapy treatments
North Carolina Medicaid now allows providers to participate in the Cell and Gene Therapy (CGT) Access Model, providing eligible Medicaid enrollees access to cell and gene therapy treatments at reduced costs. Prior authorization is required for all CGT treatments through UnitedHealthcare Community Plan, with specific billing procedures for different drug therapies.
UnitedHealthcare · Effective Dec 1, 2025Medium impact
North Carolina Medicaid: Prior authorization updates for specialty pharmacy medications
Starting December 1, 2025, UnitedHealthcare Community Plan in North Carolina will require prior authorization for 10 specialty gene and cell therapy medications. Some therapies require contacting Optum Transplant Services directly at 888-805-1802 instead of using the standard portal.
Aetna · Identified Aug 19, 2026Medium impact
Voretigene Neparvovec-rzyl (Luxturna) (CPB 0927, reviewed 2026-04-20)
Aetna covers voretigene neparvovec-rzyl (Luxturna) for commercial medical plans, and precertification is required of all Aetna participating providers and members in applicable plan designs. Aetna considers one-time administration per eye medically necessary for biallelic RPE65 mutation-associated retinal dystrophy when the member meets the listed criteria. Repeat administration in the same eye is considered experimental, investigational, or unproven, and the medication must be prescribed by or in consultation with an ophthalmologist.
Premera Blue Cross · Identified Jun 18, 2026Medium impact
Medical Policy and Coding Updates - January 2019
Effective January 1, 2019, Tisagenlecleucel code Q2042 and breast MRI codes 77046, 77047, 77048 and 77049 are now reviewed by AIM Specialty Health and require prior authorization, and A9584 (iodine I-123 ioflupane) is now reviewed for medical necessity and requires prior authorization. Breast MRI codes 77058 and 77059 are no longer reviewed by AIM Specialty Health, and the CAR-T codes 0537T through 0540T are listed as not reviewed and noncovered. Effective January 4, 2019, a long list of genetic testing codes beginning with 81120 and 81121 is now reviewed by AIM Specialty Health and requires prior authorization.
Independence Blue Cross · Identified Jun 19, 2026Low impact
MA08.094c, Voretigene Neparvovec-rzyl (Luxturna®)
This is a reissue with no substantive changes to MA08.094c covering voretigene neparvovec-rzyl (Luxturna®) for RPE65-associated retinal dystrophy. The policy was reissued on 04/01/2026 as part of the annual review process, confirming Independence Blue Cross's continuing coverage position. No billing codes, coverage criteria, or medical necessity requirements have been modified.
Independence Blue Cross · Identified Jun 19, 2026Low impact
MA08.094c, Voretigene Neparvovec-rzyl (Luxturna®)
Independence Blue Cross reissued MA08.094c (Voretigene Neparvovec-rzyl/Luxturna®) with NO SUBSTANTIVE CHANGES on 04/01/2026 as part of their annual review process. This is an informational reissue only; all coverage criteria, medical necessity requirements, and billing codes remain unchanged from the 01/01/2024 effective version.
Independence Blue Cross · Identified Jun 19, 2026Low impact
08.01.44c, Voretigene Neparvovec-rzyl (Luxturna®)
This is a reissue with no substantive changes to Independence Blue Cross Commercial Medical Policy 08.01.44c for voretigene neparvovec-rzyl (Luxturna). The policy maintains existing coverage criteria for RPE65 mutation-associated retinal dystrophy treatment and continues to use HCPCS code J3398. No billing workflow changes are required.
Independence Blue Cross · Identified Jun 19, 2026Low impact
08.01.44c, Voretigene Neparvovec-rzyl (Luxturna®)
This is a reissue with no material changes to Independence Blue Cross's policy on Luxturna (voretigene neparvovec-rzyl) for RPE65-associated retinal dystrophy. The policy maintains existing coverage criteria, HCPCS code J3398, and medical necessity requirements. No billing workflow updates are required.

Watch J3398

Get one email when a payer policy names J3398, a payer adds or drops it from a prior auth list, or Medicare changes its NCCI pairs, unit limit, payment or coverage articles.

No account needed. We send a confirmation link first, and every email has a one-click stop link.

REFERENCE DATA

Payers with rules18

Payers requiring prior auth18

Aetna · Effective November 1, 2026
Prior authorization required
Participating provider precertification list for Aetna
Anthem BCBS · Effective November 1, 2026
Prior authorization required
Anthem Local PPO Precertification/Prior Authorization List (California | Anthem Blue Cross | Commercial)
Fidelis Care · Effective November 1, 2026
Prior authorization required
Fidelis Care Metal-Level Products authorization grid

FREQUENTLY ASKED QUESTIONS

Does Aetna require prior authorization for J3398?

Aetna lists J3398 on Participating provider precertification list for Aetna for commercial plans (list dated November 1, 2026). Verify with the payer before scheduling.

Does Ambetter require prior authorization for J3398?

Ambetter lists J3398 on Ambetter from Arizona Complete Health CMS-0057-F prior authorization requirements for exchange plans (list dated December 31, 2025). Verify with the payer before scheduling.

Does AmeriHealth Caritas require prior authorization for J3398?

AmeriHealth Caritas lists J3398 on AmeriHealth Caritas Louisiana prior authorization service list for medicaid managed plans. Verify with the payer before scheduling.

Does Anthem BCBS require prior authorization for J3398?

Anthem BCBS lists J3398 on Anthem Local PPO Precertification/Prior Authorization List (California | Anthem Blue Cross | Commercial) for commercial plans (list dated November 1, 2026). Verify with the payer before scheduling.

Does BCBS Arizona require prior authorization for J3398?

BCBS Arizona lists J3398 on AZ Blue Standard Prior Authorization Requirements Code List (Updated 10/01/2026) for commercial plans (list dated October 1, 2026). Verify with the payer before scheduling.

What insurance policy changes affect HCPCS J3398?

There are 10 tracked policy changes affecting HCPCS J3398, including updates from BCBS Tennessee, UnitedHealthcare, Aetna. Each change may modify coverage criteria, reimbursement rates, or prior-authorization requirements.

Which payers have updated policy for HCPCS J3398?

Payers that have issued tracked updates for HCPCS J3398 include: BCBS Tennessee, UnitedHealthcare, Aetna, Premera Blue Cross, Independence Blue Cross.

How do I get notified when HCPCS J3398 policy changes?

Create a free account at PolicyChanges.app and save a search filtered to HCPCS J3398. You will get an email when new policy changes reference this code: daily or weekly, your choice, on every plan.

Why do payers change policies for HCPCS J3398?

Payers revise policies for individual billing codes to align with updated clinical guidelines, CMS rule changes, fraud and abuse prevention measures, or network cost-management goals. Changes can affect medical necessity criteria, place-of-service restrictions, bundling rules, or whether a code requires prior authorization.

See every payer rule for J3398

Prior authorization lists, coverage criteria, NCCI edits and Medicare coverage articles for J3398 in one place.

See every payer rule

All billing codes J3590 C9399 J3490 99215 99213 99202

Get alerts for changes like this

Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.

Create a free alert How Policy Monitoring works

Velaglucerase Alfa (VPRIV®)

North Carolina Medicaid: Billing guidance for cell and gene therapy treatments

North Carolina Medicaid: Billing guidance for cell and gene therapy treatments

North Carolina Medicaid: Prior authorization updates for specialty pharmacy medications

Voretigene Neparvovec-rzyl (Luxturna) (CPB 0927, reviewed 2026-04-20)

Medical Policy and Coding Updates - January 2019

MA08.094c, Voretigene Neparvovec-rzyl (Luxturna®)

MA08.094c, Voretigene Neparvovec-rzyl (Luxturna®)

08.01.44c, Voretigene Neparvovec-rzyl (Luxturna®)

08.01.44c, Voretigene Neparvovec-rzyl (Luxturna®)

Prior authorization required

Prior authorization required

Prior authorization required

Does Aetna require prior authorization for J3398?

Does Ambetter require prior authorization for J3398?

Does AmeriHealth Caritas require prior authorization for J3398?

Does Anthem BCBS require prior authorization for J3398?

Does BCBS Arizona require prior authorization for J3398?

What insurance policy changes affect HCPCS J3398?

Which payers have updated policy for HCPCS J3398?

How do I get notified when HCPCS J3398 policy changes?

Why do payers change policies for HCPCS J3398?